Larimar Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Larimar Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2013 to Q2 2024.
  • Larimar Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.6M, a 159% decline year-over-year.
  • Larimar Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$58.3M, a 78.7% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$36.9M, a 4.51% decline from 2022.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.4M, a 30.2% increase from 2021.
  • Larimar Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50.6M, a 19.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$58.3M -$21.6M -$13.3M -159% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$45.1M -$14.7M -$8.13M -125% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$36.9M -$13M -$3.57M -37.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$33.4M -$9.06M -$744K -8.94% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$32.6M -$8.37M +$301K +3.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$32.9M -$6.53M +$2.42M +27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$35.4M -$9.43M -$291K -3.19% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$35.1M -$8.32M +$8.49M +50.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$43.5M -$8.67M +$3.94M +31.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$47.5M -$8.94M +$3.15M +26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$50.6M -$9.13M +$5.07M +35.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$55.7M -$16.8M -$6.53M -63.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$49.2M -$12.6M -$1.28M -11.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$47.9M -$12.1M -$5.41M -81.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$42.5M -$14.2M -$6.95M -95.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$35.5M -$10.3M -$1.65M -19.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$33.9M -$11.3M -$7.63M -206% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$26.3M -$6.67M -$1.95M -41.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$24.3M -$7.25M +$7.32M +50.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-05
Q3 2019 -$31.6M -$8.63M +$6.44M +42.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$38.1M -$3.7M +$12.1M +76.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$50.1M -$4.72M +$11.2M +70.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$61.4M -$14.6M -$1.49M -11.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$59.9M -$15.1M -$2.48M -19.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$57.4M -$15.8M -$2.43M -18.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$55M -$16M -$2.95M -22.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$52M -$13.1M -$2.65M -25.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$49.4M -$12.6M +$2.09M +14.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$51.5M -$13.3M +$1.68M +11.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$53.2M -$13M +$4.73M +26.6% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$57.9M -$10.4M +$12.7M +55% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$70.6M -$14.7M +$5.21M +26.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$75.8M -$15M +$2.73M +15.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$78.6M -$17.7M -$4.26M -31.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$74.3M -$23.2M -$12.2M -112% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$62M -$19.9M -$5.2M -35.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$56.8M -$17.8M -$11.4M -177% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$45.5M -$13.5M -$9.01M -202% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$36.5M -$10.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$14.7M -$11.2M -319% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$6.4M -$3.26M -104% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.46M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 -$3.5M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$3.14M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.